baber/WOPTO huggingface dataset:
Patent AU-6302386-A (AU)
Title: Storage stable paper size composition containing ethyoxylated castor oil
Inventor: MAZZARELLA EMIL D
IPC: D21H17/16
Filed: 1986-09-22
Abstract: A shelf stable paper size is prepared from a mixture of a substituted cyclic dicarboxylic acid anhydride and an ethoxylated castor oil.
Patent AU-6415986-A (AU)
Title: Damage resistant decorative laminate
Inventor: PARK JOHN
IPC: D21H27/28
Filed: 1986-10-17
Abstract: Decorative laminate having improved resistance against marring, abrasion, staining and crocking, and method for the preparation thereof, the laminate comprising a substrate and a decorative sheet, the decorative sheet having on the exposed surface a layer consisting essentially of a thermoset resin, substantially fully hydrolyzed polyvinyl alcohol, fumed amorphous silica, and particulate abrasive material having a hardness higher than that of silica. Abrasion resistance greater than 3000 cycles (NEMA Wear) by the NEMA test LD 3-3.01 is obtained in combination with improved mar resistance.
Patent AU-6639098-A (AU)
Title: Protective materials for optical fibers which do not substantially discolor
Inventor: SZUM DAVID MICHAEL
IPC: G02B6/00
Filed: 1998-03-05
Abstract: Radiation-curable compositions are disclosed which, after cure, are substantially non-yellowing. The compositions are particularly tailored for coating and bundling of optical fibers. A first preferred composition is based on a polyether-type of oligomer diluted with reactive diluents. Isocyanurate structures are included in the composition to raise Tg. A second preferred composition is based on fatty oil comprising (meth)acrylate groups and bisphenol A derivatives comprising (meth)acrylate groups. Photoinitiators can be included to increase cure speed. The formulations do not include material amounts of ingredients which tend to cause yellowing or, in theory, extended conjugation in the cured compositions.
Patent AU-6724590-A (AU)
Title: Oligonucleotide analogs with novel linkages
Inventor: MATTEUCCI MARK
IPC: A61K48/00
Filed: 1990-10-24
Abstract: The instant invention is directed to oligonucleotide compounds wherein on or more phosphodiester linkages between adjacent nucleotides are replaced by a formacetal/ketal type linkage. The nucleotides of the present invention are resistant to nucleases and do not need to exhibit the diastereomerism characteristic of many other oligonucleotide compounds and thus are capable of strong hybridization to target RNA or DNA. These oligonucleotide compounds are useful in therapies which modulate gene expression using antisense or other specifically binding oligomers.
Patent AU-6725996-A (AU)
Title: Removal of sulfides from alcoholic beverages
Inventor: ELLSWORTH ROBERT M
IPC: C12H1/044
Filed: 1996-08-14
Abstract: Wines and other alcoholic beverages are treated to remove sulfides by passing the beverage through a filter medium comprising polyvinyl polypyrrolidone, polyvinylimidazole, or a copolymer of the monomers of these two polymers, the polymer or copolymer having been pretreated with a solution of a metallic salt, preferably copper sulfate or silver nitrate.
Patent AU-6795400-A (AU)
Title: Methods and devices for reducing the mineral content of a region of non-intimal vascular tissue
Inventor: CONSTANTZ BRENT R
IPC: A61F2/958
Filed: 2000-08-21
Abstract: Methods and devices for reducing the mineral content of a region of non-intimal vascular tissue are provided. In the subject methods, an isolated local environment that includes the region to be demineralized is produced. The pH of the local environment is then reduced to a subphysiologic level, e.g. by flushing with an acidic dissolution fluid, for a period of time sufficient for the mineral content of the region to be reduced. The devices of the subject invention are characterized by comprising a means for producing an isolated local environment that includes a non-intimal region of vascular tissue. Also provided are kits for practicing the subject methods.
Patent AU-6830996-A (AU)
Title: Unactivated oocytes as cytoplast recipients for nuclear transfer
Inventor: CAMPBELL KEITH HENRY STOCKMAN
IPC: A61K35/54
Filed: 1996-08-30
Abstract: A method of reconstituting an animal embryo involves transferring a diploid nucleus into an oocyte which is arrested in the metaphase of the second meiotic division. The oocyte is not activated at the time of transfer, so that the donor nucleus is kept exposed to the recipient cytoplasm for a period of time. The diploid nucleus can be donated by a cell in either the GO or G1 phase of the cell cycle at the time of transfer. Subsequently, the reconstituted embryo is activated. Correct ploidy is maintained during activation, for example, by incubating the reconstituted embryo in the presence of a microtubule inhibitor such as nocodazole. The reconstituted embryo may then give rise to one or more live animal births. The invention is useful in the production of transgenic animals as well as non-transgenics of high genetic merit.
Patent AU-6851696-A (AU)
Title: Compositions containing hydroperoxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
Inventor: YANNI JOHN M
IPC: A61K31/202
Filed: 1996-08-19
Abstract: Compositions containing a HETE derivative and methods of use for treating dry eye are disclosed.
Patent AU-6875791-A (AU)
Title: Improved system for the transdermal application of pharmacologically active compounds at controlled ph
Inventor: GUPTE ARUN RAJARAM
IPC: A61L15/44
Filed: 1990-11-29
Abstract: The invention concerns the improved transdermal application of pharmacologically active compounds.
Patent AU-6964900-A (AU)
Title: Method for eliminating staphylococcus aureus, novel microorganism of genus brachybacterium, and care garment, care sheet or care bedclothes, each being immobilized with microorganism of genus brachybacterium
Inventor: ITO EIZO
IPC: A01N63/20
Filed: 2000-10-31
Abstract: A method for eliminating Staphylococcus aureus is disclosed, including inoculating a microorganism of the genus Brachybacterium to Staphylococcus aureus to eliminate Staphylococcus aureus. A care garment, a care sheet or care bedclothes, each being immobilized with a microorganism of genus Brachybacterium, is also disclosed. One of the microorganisms of the genus Brachybacterium useful in the invention is novel and is deposited as a bacterial strain AAA-a of the genus Brachybacterium (Accession No. FERM BP-6848) in the International Depositary Authority for the deposit of microorganism.
Patent AU-7047900-A (AU)
Title: Method of broadcasting a quality over-the-air multicast
Inventor: SEGURA LOUIS
IPC: H04B7/26
Filed: 2000-09-01
Abstract: A method in a radio telecommunications network of broadcasting data in an over-the-air multicast to a group of mobile terminals. Statistics from regular point-to-point cellular transmissions to build a statistical database for each base station. The statistical data indicate the optimal signal quality that users normally experience when operating in that cell. From this data, a minimum transmission quality (TQmin) that a mobile terminal must receive for the type of data being broadcast is determined. The method then broadcasts a test transmission to the mobile terminals, and includes a maximum transmission quality (TQmax) in order to limit the number of responses. A response is then received from a mobile terminal representative of the group, the response including an indication of the received transmission quality. The method then determines whether the received transmission quality was greater than or equal to TQmin. If the received transmission quality was greater than or equal to TQmin, the data is broadcast in the over-the-air multicast to the group of mobile terminals.
Patent AU-7234091-A (AU)
Title: Lithographic plates
Inventor: TREVERTON JOHN ALFRED
IPC: B41N1/14
Filed: 1991-02-06
Abstract: PCT No. PCT/GB91/00180 Sec. 371 Date Sep. 30, 1992 Sec. 102(e) Date Sep. 30, 1992 PCT Filed Feb. 6, 1991 PCT Pub. No. WO91/42140 PCT Pub. Date Aug. 22, 1991.A lithographic plate comprising a substrate carrying an oxide layer derived from a Type A sol is disclosed. The substrate may be metal, e.g. aluminum or steel, and may be in a mill finished state or grained or otherwise profiled. Type A sols have polynuclear cations but no specific particles and may be formed by peptising basic salts with acids. The sol may include an inorganic passenger powder which may impart a desired topography to the coating layer.
Patent AU-7291087-A (AU)
Title: Strengthened high impact styrenic polymers showing improved physical-mechanical properties
Inventor: CIGNA GIUSEPPE
IPC: C08L51/06
Filed: 1987-05-13
Abstract: Strengthened high impact resistant styrene polymers showing improved physical-mechanical properties, particularly a high resilience at room temperature and at lower temperatures and break elongation, containing as a dispersed phase an olefinic rubber, preferably an ethylene-propylene or an ethylene-propylene-diene rubber and a polyolefin. The amount of the polyolefin is up to 15% by weight.
Patent AU-7475294-A (AU)
Title: A brushless spindle motor for a grinding machine including hydrostatic bearings
Inventor: PFLAGER WILLIAM W
IPC: B23Q11/12
Filed: 1994-07-29
Abstract: A machine tool in which a tool or workpiece is mounted on a spindle (5) supported in anti-friction hydrostatic oil bearings (64, 65) lying in a closed-loop oil conduit including a reservoir (20). The spindle is driven by an electric motor (40) mounted at one end thereof. The motor has a liquid-cooled jacket (17) supplied in another closed-loop with liquid drawn from the same reservoir, so that the same liquid is used both to cool the motor and to lubricate the bearings. <IMAGE>
Patent AU-7495394-A (AU)
Title: Antiparasitic agents based on avermectin substituted in the 5-position by alkylidene
Inventor: DUTTON CHRISTOPHER JAMES
IPC: C07H19/01
Filed: 1994-07-22
Abstract: Antiparasitic avermectin derivatives of formula (I), where the broken line represents an optional bond, R1 and R4 are independently H, OH, halo, oximino, or an organic radical, R2, R6 and R7 are organic radicals and R3 is alpha-oleandrosyl or 4'-(alpha-oleandrosyl)-alpha-oleandrosyl optionally substituted at the 4'- or 4''-position, and R12 and R13 are independently H, CN, CONH2, C1-C8 alkyl or aryl optionally substituted with at least one halo, OH, C1-C8 alkylthio group.
Patent AU-7555296-A (AU)
Title: Secure mailer/receipt business form
Inventor: GOLDRING TONY STEVEN
IPC: B65D27/00
Filed: 1996-11-15
Abstract: PCT No. PCT/AU96/00726 Sec. 371 Date Aug. 13, 1997 Sec. 102(e) Date Aug. 13, 1997 PCT Filed Nov. 15, 1996 PCT Pub. No. WO97/20700 PCT Pub. Date Jun. 12, 1997A secure mailer/receipt business form including a top and bottom ply and at least one intermediate ply constituting a separable receipt part which receipt part is associated with image transfer material for imparting information onto the bottom ply, the rear face of the top ply including a coated adhesive material covering at least part of the surface, adhesive being coated with a releasable non-adhesive backing materials connected to the separable receipt part such that withdrawal of the separable receipt part will release the backing material to expose the adhesive layer to adhere the top ply to the top face of the bottom ply thereby sealing the top and bottom plies together after removal of the receipt part to restrict tampering with the remaining business form without damage to the form.
Patent AU-7617000-A (AU)
Title: Method and system for querying attributes in a cellular communications system
Inventor: BENDER PAUL E
IPC: H04M3/00
Filed: 2000-09-27
Abstract: In communications networks, network elements require knowledge of other network elements such as when they are added to or deleted from the network configuration and the resources they have available. The protocol allows network elements to communicate resource information dynamically and directly. The protocol also allows direct exchange of network configuration information between network elements for determining wireless communications network paging areas.
Patent AU-7667501-A (AU)
Title: Composition for the prevention and/or treatment of lipid metabolism disorders and allergic forms
Inventor: POLA PIETRO
IPC: A23L33/15
Filed: 2001-07-24
Abstract: A composition is disclosed which can be used as a health food/dietary supplement or as a drug for the prevention and/or treatment of lipid metabolism disorders and allergic forms and for activating organic defences against infections and tumor processes, containing as its characterizing components isovaleryl L-carnitine and a polysaccharide selected from glucans and galactans.
Patent AU-7734894-A (AU)
Title: Immunoreactive antigens of hepatitis e virus
Inventor: ANDERSON DAVID ANDREW
IPC: A61P31/12
Filed: 1994-09-23
Abstract: The present invention relates generally to molecules such as peptides, polypeptides and proteins which carry epitopes and in particular B cell epitopes from antigenic proteins encoded by Hepatitis E Virus. These molecules are selectively immunoreactive to convalescent and/or acute phase circulating antibodies to the Hepatitis E Virus and are useful in the development of diagnostic therapeutical and prophylactic agents for Hepatitis E Virus.
Patent AU-7791994-A (AU)
Title: A gas powered heating device
Inventor: OGLESBY JOHN PAUL
IPC: A45D1/02
Filed: 1994-10-03
Abstract: PCT No. PCT/IE94/00047 Sec. 371 Date Apr. 1, 1996 Sec. 102(e) Date Apr. 1, 1996 PCT Filed Oct. 3, 1994 PCT Pub. No. WO95/09712 PCT Pub. Date Apr. 13, 1995A gas powered soldering tool (1) comprising a main body member (4) terminating in a soldering tip portion (8) has a combustion chamber (10) located therein. A gas catalytic combustion element (12) is located in the combustion chamber (10), and fuel gas is delivered into the combustion chamber (10) from a jet nozzle (15) and an air mixing venturi bore (17). A temperature responsive controller (28) for controlling the fuel gas supply to the jet nozzle (15) comprises a valve (39) having a valving member (58) which is operable by a permanent magnet (63) slidably located in a bore (64). A first member (70) of thermomagnetic material the Curie point of which is substantially similar to the temperature at which the main body member (4) is to be controlled is located at one end of the bore (64). The magnetic attraction between the first member (70) and the permanent magnet (63) is greater than the magnetic attraction between a second member (71) in the bore (64) and the permanent magnet (63) when the first member (70) is magnetic, thereby maintaining the valve (39) open, and vice versa when the first member (70) becomes non-magnetic for closing the valve (39).
Patent AU-7952794-A (AU)
Title: Device at a panel-wall which is built up by panel elements
Inventor: HOLMSTEDT LASSE
IPC: A47B96/06
Filed: 1994-10-12
Abstract: The present invention refers to device (1) at upright like support rails (4) and transverse to said rails (4) connectable panel elements (5) which panel elements are buildable to a panel lining (2), with groove-shaped receiving spaces (6) formed between the panel elements (5) and in which support elements (7) intended for coupling are receivable. Thereby rail-shaped fastening profiles (8) exhibit each other off faced integrated portions of a hook part (11) and coupling means (12), respectively, whereby the hook part (11) is receivable in receiving slots (13) arranged in a lateral flange (14) protruding from the fastening location (16) of the rails.
Patent AU-7981291-A (AU)
Title: Controlled release vehicle
Inventor: CHANG AN-CHENG
IPC: A61F13/15
Filed: 1991-05-07
Abstract: A new controlled release vehicle which acts by breakdown of the entrapping material upon hydration has been developed. The preferred release vehicle is made of a carboxylated cellulose, e.g., carboxymethylcellulose, which is treated with a cross-linking agent such as aluminum ions and, preferably, a hydrophobicity agent such as acetic acid. The vehicle is broken down by a release agent, e.g., cellulase, which may be coated on the vehicle together with a coating agent, e.g., hydroxypropylcellulose. The vehicle is dried, entrapping the molecular to be entrapped, e.g., an enzyme, and hydration activates the cellulase which breaks down the carboxymethylcellulose, releasing the entrapped molecular.
Patent AU-7994398-A (AU)
Title: Material intended to remineralise organomineral tissues
Inventor: MALMAGRO MANUEL VALIENTE
IPC: A61K6/838
Filed: 1997-12-30
Abstract: Together with other accessory products, includes a mixture of ion-exchange resins, cationic and anionic, charged with Ca<2+>, F<-> and PO4<3-> ions, in an approximate molar ratio of 2:1:1, respectively. Particularly preferred is a material in which the resins also have a charge of Zn<2+> ions representing a proportion of less than 1%, preferably close to 0.2% of the dry weight of the resin. The preferred resins are those whose base is cross-linked polystyrene with 2-14% divinylbenzene. The material is useful as first filler in the treatment of caries, especially deep caries, leading to remineralization of the dentin with a composition very close to the original composition, together with high microhardness. It is also useful as a component of dentifrice products such as pastes, elixirs and dental floss.
Patent AU-8171091-A (AU)
Title: Halogenoalkyl azolyl derivatives
Inventor: JAUTELAT MANFRED
IPC: C07D521/00
Filed: 1991-08-08
Abstract: Novel haloalkylazolyl derivatives of the formula <IMAGE>  in which   R<1> represents optionally substituted alkyl, optionally substituted alkenyl, optionally substituted cycloalkyl or optionally substituted aryl,   R<2> represents hydrogen, alkyl, alkenyl, acyl or aralkyl,   X<1> represents halogen,   X<2> represents halogen,   n represents 0 or 1 and   Y represents nitrogen or a CH group, and their acid addition salts and metal salt complexes, a plurality of processes for the preparation of the novel substances and their use as microbicides in plant protection and in materials protection.
Patent AU-8310198-A (AU)
Title: Method of treatment of diabetic neuropathy and vascular change or diabetic retinopathy
IPC: A61K31/15
Filed: 1998-09-04
Abstract: Compositions containing as the active ingredient a spin-trapping reagent, preferably  alpha -phenyl butyl nitrone (PBN) or spin-trapping derivatives thereof, in a suitable pharmaceutical carrier for administration to a patient are disclosed for treating or preventin symptoms associated with aging or other conditions associated with oxidative tissue damage. Other spin-trapping agents can also be used, such as 5,5-dimethyl pyrroline N-oxide (DMPO) or  alpha -(4-pyridyl 1-oxide)-N-tert-butylnitrone (POBN), and other spin-trapping derivatives thereof. These compositions and methods are useful in the treatment of age-related disorders, pre-surgical and/or pre-anesthetic preparation or administration of chemotherapeutic agents, and in the treatment of disorders or trauma of the brain, cardiovascular system, and lymphatic system. Studies in animals demonstrate that administration of compound for a two week period reduces the level of oxidized brain enzymes ot normal and restores memory to the sam level as tested in young control animals.
Patent AU-8335291-A (AU)
Title: Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals
Inventor: GEISSLINGER GERD DR
IPC: C07C57/58
Filed: 1991-08-19
Abstract: The present invention provides a medicament for the treatment of painful and/or inflammatory diseases and/or of fever with flurbiprofen, wherein the flurbiprofen is pure or preponderantly R(-)-flurbiprofen worked up in combination with conventional pharmaceutical carriers and adjuvants, to give a medicament.
Patent AU-8337798-A (AU)
Title: Process for the preparation of trifluoromethyl acetophenone
IPC: C07C45/42
Filed: 1998-06-17
Abstract: A process for the preparation of a compound of formula Iwherein Y is a group that is inert during preparation of the compound and m is from 0 to 4 is described. The process broadly involves the steps of a) reacting a compound of formula IIwherein X is chlorine, bromine or iodine, and Y and m are as defined above, with a vinylether or an enamide in a solvent, a base and a catalytic amount of a palladium compound and a phosphine ligand. The resulting intermediate is then hydrolyzed to the compound of formula I.
Patent AU-8544191-A (AU)
Title: Adaptor top
Inventor: HANSEN IB
IPC: A61M15/00
Filed: 1991-09-20
Abstract: A plastic top for adapting to a chosen syringe (14) a standard cartridge (8) of the kind having a neck (9) with a flange (10) and being closed by a rubber membrane (11) sealingly secured against the flange (10) by a metal cover (12) having its edge beaded behind the flange. This plastic top has a bore (2) for receiving the neck part (9) of the cartridge (8), which bore (2) has a diameter making it fit over the metal cover (12) and is provided with protrusions (3;9) gripping behind the edge of the metal cover (12) when the neck part (9) is inserted in the bore. The outer contour of the plastic top is adapted to the syringe type in which the cartridge is going to be used. The plastic top is provided with a thread (5;18) coaxial with the bore to receive a needle hub (13) in a way making its needle (15) penetrate the membrane (11) of the cartridge (8) when the hub (13) is mounted on the thread (5) of the plastic top.
Patent AU-8756591-A (AU)
Title: Cell growth inhibitors
Inventor: MALLUCCI LIVIO
IPC: C07K19/00
Filed: 1991-10-30
Abstract: PCT No. PCT/GB91/01898 Sec. 371 Date Apr. 30, 1993 Sec. 102(e) Date Apr. 30, 1993 PCT Filed Oct. 30, 1991 PCT Pub. No. WO92/07938 PCT Pub. Date May 14, 1992Non-agglutinating  beta -galactoside binding proteins (GBP), both the natural proteins and proteins produced by recombinant DNA technology, are provided for use as inhibitors and regulators of vertebrate cell growth and as anti-viral agents. Methods of producing the GBP's are also described. The GBP's show a powerful growth inhibitory effect against human cancer cells making them potentially useful therapeutic agents in the treatment of malignant disease and also show an inhibitory effect on viral replication making them potentially useful as anti-viral agents.
Patent AU-8925191-A (AU)
Title: High power lamp
Inventor: DOLAN JAMES T
IPC: H01J17/20
Filed: 1991-10-24
Abstract: A high power lamp (2) that may be either an electrodeless or arc lamp is disclosed. The lamp contains a fill of either selenium or sulfur and a small amount of rare gas (e.g. argon or xenon).
Patent AU-8946901-A (AU)
Title: Device for embossing and/or satin-finishing a flat material
Inventor: BOEGLI CHARLES
IPC: B31F1/07
Filed: 2001-10-03
Abstract: A device for satinizing and simultaneously embossing flat materials that includes at least two embossing rolls. One roll is connected to a driving system. The rolls are adapted to be driven individually or in common and are adapted to be resiliently applied against each other. Pyramidal or conical teeth of the rolls have flattened tips. The teeth of at least one roll are shaped so as to produce embossed signs in corresponding locations of the passing flat material so that the appearance of the embossed signs changes according to at least one of a viewing angle of the observer, a kind, and the position of the lighting source.
Patent AU-9133791-A (AU)
Title: Tapetum-specific promoters from brassicaceae spp
Inventor: SCOTT RODERICK JOHN
IPC: C12N15/82
Filed: 1991-12-24
Abstract: The present invention provides recombinant or isolated DNA comprising a promoter having tapetum-specific activity. The DNA encodes a promoter which naturally drives expression of (i) a gene encoding a 10.3 kDa tapetum protein in Brassica napus which gene hybridises under stringent conditions to the cDNA shown in figure 5; or (ii) a gene encoding a tapetum protein from Brassicaceae which gene hybridises under stringent conditions to the gene shown in figure 4, the gene shown in figure 7, the cDNA shown in figure 1 or the cDNA shown in figure 5.